跳至主要内容
临床试验/NCT07575230
NCT07575230Enrolling By Invitation4 期

Non-Opioid Pain Management After Mohs Reconstruction: An Investigator-Initiated, Prospective, Randomized Clinical Trial of Suzetrigine vs Hydrocodone/Acetaminophen

Baylor Research Institute1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2025年11月3日最近更新:

试验速览

阶段
4 期
状态
Enrolling By Invitation
入组人数
75
试验地点
1

研究概览

简要总结

To compare suzetrigine versus hydrocodone/acetaminophen for postoperative pain control following dermatologic surgery.

详细描述

This study is a randomized, controlled trial that is evaluating the safety and efficacy of suzetrigine as a postoperative pain medication compared to the standard of care Hydrocodone/Acetaminophen in patients undergoing Mohs micrographic surgery (MMS) who are at high-risk for postoperative pain and opioid use. The goal is to reduce opioid prescription use and give patients a non-opioid pain medication option for particularly painful surgeries. Patients will be randomized into one of two groups, one group will receive the interventional medication and the other the standard of care medication.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 89 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • adults between the age of 18-89
  • individuals who have a cutaneous tumor treated by MMS

排除标准

  • individuals younger than 18 and older than 89
  • individuals taking medications that interact with the CYP3A (Cytochrome P450 3A) pathway
  • individuals with liver disease

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验